27 insiders reported 67 Form 4 transactions for COGNITION THERAPEUTICS INC (CGTX) over the past 18 months (most recent 2026-06-22). Recent activity: Monia Brett P (Director) Buy 25,000 shares, Wallace Peggy (Director) Buy 25,000 shares, BIOS Memory SPV I, LP (Director) Buy 25,000 shares, BIOS Fund I, LP (Director) Buy 25,000 shares, BIOS Fund I QP, LP (Director) Buy 25,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-22 | Monia Brett P | Director | Buy | 25,000 | $0 |
| 2026-06-22 | Wallace Peggy | Director | Buy | 25,000 | $0 |
| 2026-06-22 | BIOS Memory SPV I, LP | Director | Buy | 25,000 | $0 |
| 2026-06-22 | BIOS Fund I, LP | Director | Buy | 25,000 | $0 |
| 2026-06-22 | BIOS Fund I QP, LP | Director | Buy | 25,000 | $0 |
| 2026-06-22 | BIOS Fund II, LP | Director | Buy | 25,000 | $0 |
| 2026-06-22 | BIOS Fund II QP, LP | Director | Buy | 25,000 | $0 |
| 2026-06-22 | RICHSTONE ELLEN B | Director | Buy | 25,000 | $0 |
| 2026-06-22 | Bios Equity Partners II, LP | Director | Buy | 25,000 | $0 |
| 2026-06-22 | Bios Equity Partners, LP | Director | Buy | 25,000 | $0 |
| 2026-06-22 | BIOS Advisors GP, LLC | Director | Buy | 25,000 | $0 |
| 2026-06-22 | BIOS Capital Management, LP | Director | Buy | 25,000 | $0 |
| 2026-06-22 | Khattar Jack A. | Director | Buy | 25,000 | $0 |
| 2026-06-22 | Fletcher Aaron G.L. | Director | Buy | 25,000 | $0 |
| 2026-05-04 | Doyle John Brendan | Chief Financial Officer | Sell | 8,567 | $10,966 |
| 2026-04-20 | Doyle John Brendan | Chief Financial Officer | Buy | 10,000 | $11,300 |
| 2026-04-20 | Ricciardi Lisa | CEO & President | Buy | 9,175 | $10,092 |
| 2026-04-20 | Caggiano Anthony | Chief Medical Officer | Buy | 10,000 | $11,100 |
| 2026-02-18 | Ricciardi Lisa | CEO & President | Sell | 5,850 | $6,552 |
| 2026-02-18 | Caggiano Anthony | Chief Medical Officer | Sell | 4,680 | $5,242 |
| 2026-02-18 | Doyle John Brendan | Chief Financial Officer | Sell | 1,560 | $1,747 |
| 2026-02-05 | Ricciardi Lisa | CEO & President | Sell | 26,036 | $29,160 |
| 2026-02-05 | Doyle John Brendan | Chief Financial Officer | Buy | 200,000 | $0 |
| 2026-02-05 | Doyle John Brendan | Chief Financial Officer | Sell | 26,921 | $27,729 |
| 2026-02-05 | Ricciardi Lisa | CEO & President | Buy | 800,000 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-06-22